NCT03786003

Brief Summary

This study is one of Eastern Cooperative Thoracic Oncology Projects (ECTOP-1007). The goal of this study is to determine video-assisted thoracoscopic surgery is non-inferior to thoracotomy in terms of disease-free survival for solid clinical stage T1N0M0 NSCLC.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,086

participants targeted

Target at P75+ for not_applicable

Timeline
21mo left

Started Feb 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress71%
Feb 2022Feb 2028

First Submitted

Initial submission to the registry

December 19, 2018

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 24, 2018

Completed
3.1 years until next milestone

Study Start

First participant enrolled

February 9, 2022

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 9, 2025

Completed
3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

February 9, 2028

Expected
Last Updated

July 21, 2023

Status Verified

July 1, 2023

Enrollment Period

3 years

First QC Date

December 19, 2018

Last Update Submit

July 19, 2023

Conditions

Keywords

Video-Assisted Thoracic SurgeryThoracotomyEarly-stage NSCLC

Outcome Measures

Primary Outcomes (1)

  • Disease-free survival

    Disease-free survival means the period after surgery when no disease can be detected.

    3 years after the surgery

Secondary Outcomes (3)

  • Overall survival

    3 years after the surgery

  • Rate of patients with perioperative complication

    1 month after surgery

  • Pain degree and quality of life

    1 years after the surgery

Study Arms (2)

VATS

EXPERIMENTAL

Video-assisted thoracoscopic surgery

Procedure: VATS

Thoracotomy

ACTIVE COMPARATOR

Open surgery

Procedure: Thoracotomy

Interventions

VATSPROCEDURE

Standard video assisted thoracic surgery, no use of rib-spreader.

VATS
ThoracotomyPROCEDURE

Standard thoracotomy

Thoracotomy

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical stage T1N0M0 and surgical resectable.
  • Solid appearance on computed tomography scan.
  • Age 18 to 75 year.
  • Signed the informed consent form.

You may not qualify if:

  • Not NSCLC in pathological analysis.
  • Not lobectomy or sublobar resection.
  • History of other malignant tumors within 5 years.
  • History of thoracic surgery or unsuitable for VATS.
  • Previous radiation or chemotherapy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fudan University Shanghai Cancer Center

Shanghai, China

RECRUITING

MeSH Terms

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

Thoracic Surgery, Video-AssistedThoracotomy

Condition Hierarchy (Ancestors)

Carcinoma, BronchogenicBronchial NeoplasmsLung NeoplasmsRespiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

ThoracoscopyEndoscopyDiagnostic Techniques, SurgicalDiagnostic Techniques and ProceduresDiagnosisVideo-Assisted SurgeryMinimally Invasive Surgical ProceduresSurgical Procedures, OperativeThoracic Surgical Procedures

Study Officials

  • Shanghai Cancer Center Chen, Ph.D

    Shanghai Cancer Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Haiquan Chen, Ph.D

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director

Study Record Dates

First Submitted

December 19, 2018

First Posted

December 24, 2018

Study Start

February 9, 2022

Primary Completion

February 9, 2025

Study Completion (Estimated)

February 9, 2028

Last Updated

July 21, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will share

Study Protocol, Inform Consent Form, Clinical Study Report would be shared every 3 months after the study begin.

Shared Documents
STUDY PROTOCOL, ICF, CSR
Time Frame
Every 3 months after the study begin.

Locations